Abstract
The cytotoxicity of 48 compounds included in the MEIC (Multicenter Evaluation of In Vitro Cytotoxicity) list was determined in cultures of rat hepatocytes, McCoy, and MDBK cells. The average minimum concentration of each compound inducing cytotoxicity was measured in each cell type. The cytotoxicity values were then compared with published oral LDS p values for rats and mice. The logarithmic transformation of in vivo toxic doses and the corresponding in vitro cytotoxic concentrations showed a statistically significant correlation between the in vitro and in vivo values. The results show that an accurate in vivo LDS p dose could be predicted from in vitro data for at least 75% of the selected compounds. It is hoped that this finding will not only stimulate others to pursue in vitro technique but will eventually lead to elimination of the in vivo LD50 test.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CT50 :
-
50% cytotoxic concentration
- CT100 :
-
100% cytotoxic concentration
- DMSO:
-
dimethyl sulfoxide
- LD50 :
-
50% lethal dose
- LDH:
-
Lactate dehydrogenase
- MEIC:
-
Multicenter Evaluation of In Vitro Cytotoxicity
References
ADLER, E., BENJAMIN, S.B., and ZIMMERMAN, H.J. (1986). “Cholestatic hepatic injury related to Warfarin exposure.” Arch. Intern. Med. 46: 1837–1839.
ALDHOUS, P. (1991). “Tide turns against LD50.” Nature 352:489.
BODYAGIN, D.A., SIRKIN, A.B., LUTINOSOV., Y.V., and ZAITSEVA, L.A. (1989). “The effect on human and animal organisms of herbicide derivatives of chlorophenoxy acetic acid.” Farmakol. Toksikol. 32: 747–751.
BONDESSON, I., EKWALL, B., HELLBERG, S., ROMBERT, L., STENBERG, K., and WALUM, E. (1989). “MEIC—A new international multicenter project to evaluate the relevance to human toxicity of in vitro cytotoxicity tests.” Cell. Biol. and Toxicol. 5: 331–247.
CLOTHIER, R.H., HULME, L.M., SMITH, M., and BALLS, M. (1987). “Comparison of the in vitro cytotoxicities and acute in vivo toxicities of 59 chemicals.” Mol. Toxicol. 1: 571–577.
EKWALL, B. (1980). “Preliminary studies on the validity of in vitro measurement of drug toxicity using HeLa cells. II. Drug toxicity in the MIT-24 system compared with mouse and human lethal dosage of 52 drugs.” Toxicol. Letters. 5: 309–317.
EKWALL, B. and JOHANSSON, A. (1980). “Preliminary studies on the validity of in vitro measurement of drug toxicity using HeLa cells. I. Comparative in vitro toxicity of 27 drugs.” Toxicol. Letters. 5:299–307.
EKWALL, B. (1981). “Preliminary studies on the validity of in vitro measurement of drug toxicity using HeLa cells. IV. Therapeutic effects and side effects of 50 drugs related to the HeLa toxicity of the therapeutic concentrations.” Toxicol. Letters. 7: 359–366.
EKWALL, B. (1983). “Correlation between cytotoxicity in vitro and LD50-values.” Pharmacologica Toxicologica 52: 80–99.
EKWALL, B., GOMEZ-LECHON, M.J., HELLBERG, S., BONDESSON, I., CASTELL, J.V., JOVER, R., HOGBERG, J., PONSODA, X., ROMER, L., STENBERG, K., and WALUM, E. (1990). “Preliminary results from the scandanavian multicentre evaluation of in vitro cytotoxicity (MEIC).” Toxicol. in vitro 4: 688–691.
FRY, J.R., GARLE, M.J., HAMMOND, H.H., and HATFIELD, A. (1990). “Correlation of acute lethal potency with in vitro cytotoxicity.” Toxicol. in vitro 4: 175–178.
GUILLOUZO, C.G. and GUILLOUZO, A. (1983). Modulation of functional activities in cultured rat hepatocytes.” Mol. Cell. Biochem. 53: 35–56.
HALLE, W., GORES, E., and BAEGER, I. (1987). “Besitzt die vorhersage der LD50 mit hilfe der zellkultur allgemeingultigkeit? Pharmazie. 42: 848–850.
HEUVEL, M.J., CLARK, D.G., FIELDER, R.J., KOUNDAKJIAN, P.P., OLIVER, G.J.A., PELLING, D., TOMLINSON, N.J., and WALKER, A.P. (1990). “The international validation of a fixed dose procedure as an alternative to the classical LD50 test.” Fd. Chem. Toxicol. 28: 469–482.
MALANSKY, C.J. and WILLIAMS, G.M. (1982). “Primary cultures and the levels of cytochrome P450 in hepatocytes from mouse, rat, hamster and rabbit liver.” In vitro 18: 683–693.
MEHLMAN, M.A., PFITZER, E.A., and SCALA, R.A. (1989). “A report on methods to reduce, refine, and replace animal testing in industrial toxicology laboratories.” Cell. Biol. and Toxicol. 5: 349–358.
MEYER, H., BAUMANN, H.R., and LEMENBERGER, P. (1988). Meyler's side effects of drugs. Elsevier, Amsterdam.
MOLDEUS, P., HOGBERG, J., and ORRENIUS, S. (1978). “Isolation and use of liver cells.” Methods. Enzymol. 52: 60–71.
NOORDWIJK, A.J.V. and NOORDWIJK, J.V. (1988). “An accurate method for estimating an approximate lethal dose with few animals, tested with a Monte Carlo procedure. ” Arch. Toxicol. 61: 333–343.
ROWAN, A. (1983). “Shortcomings of LD50-values and acute toxicity testing in animals.” Acta. Pharmacol. Toxicol. 52 (Suppl. II): 52–63.
SCHALM, S.W. and DE KNEGT, R.J. (1984). Hepatic encephalopathy. Putative toxins: Phenol. Elsevier, Amsterdam.
SHRIVASTAVA, R., JOHN, G.W., RISPAT, G., CHEVALIER, A., and MASSINGHAM, R. (1991). “Can the in vivo maximum tolerated dose be predicted using in vitro techniques? A working hypothesis.“ ATLA 19: 393–402.
STRICKER, B.H. (1987). Hepatic injury by drugs and environmental toxins in the Liver Annual. Elsevier, Amsterdam.
THURMAN, R.G. and KAUFFMAN, F.C. (1980). “Factors regulating drug metabolism in intact hepatocytes.” Pharmacol. Rev. 31: 229–251.
TREVAN, J.W. (1927). “The error of determination of toxicity.” Proc. R. Soc. (Lond.) Ser. B. 101: 483–514.
ZBINDEN, G. (1990). “Alternatives to animal experimentation: developing in vitro methods and changing legislation.” Tips 11: 104–107.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shrivastava, R., Delomenie, C., Chevalier, A. et al. Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals. Cell Biol Toxicol 8, 157–170 (1992). https://doi.org/10.1007/BF00260565
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00260565